Cell Source, Inc. Share-based Payment Arrangement, Expense
Cell Source, Inc. (CLCS) reported Share-based Payment Arrangement, Expense of $104.47 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-05-14
- Cell Source, Inc. share-based payment arrangement, expense for the quarter ending 2025-03-31 was $104.47K, a 63.84% decline year-over-year.
- Cell Source, Inc. share-based payment arrangement, expense for the quarter ending 2024-03-31 was $288.89K, a 12.46% decline year-over-year.
- Cell Source, Inc. share-based payment arrangement, expense for the quarter ending 2023-06-30 was $49.02K.
- Cell Source, Inc. share-based payment arrangement, expense for the quarter ending 2023-03-31 was $330.00K.
- Cell Source, Inc. share-based payment arrangement, expense for fiscal 2024 was $288.42K, a 37.71% decline from fiscal 2023.
- Cell Source, Inc. share-based payment arrangement, expense for fiscal 2023 was $463.03K, a 494.49% increase from fiscal 2022.
- Cell Source, Inc. share-based payment arrangement, expense for fiscal 2022 was $77.89K.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|
| 2025-03-31 | $104.47K 10-Q · filed 2026-05-14 | ||
| 2024-12-31 | $288.42K 10-K · filed 2026-04-07 | ||
| 2024-03-31 | $288.89K 10-Q · filed 2026-05-14 | ||
| 2023-12-31 | $463.03K 10-K · filed 2026-04-07 | ||
| 2023-06-30 | $49.02K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-19 | $379.02K 10-Q · filed 2024-08-19 | |
| 2023-03-31 | $330.00K 10-Q · filed 2024-07-29 | ||
| 2022-12-31 | $77.89K 10-K · filed 2024-06-24 |